Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2014
09/23/2014CA2544332C Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
09/23/2014CA2543199C Use of crth2 antagonist compounds in therapy
09/23/2014CA2517101C A modified oligonucleotide for inhibition of growth hormone receptor expression
09/23/2014CA2500935C Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
09/23/2014CA2454822C Nucleic acids, polypeptides, and methods for modulating apoptosis using apoptosis-specific eif-5a
09/18/2014WO2014146137A1 Immunoassay of s-adenosylmethionine using analogs thereof and personalized therapeutics
09/18/2014WO2014146097A1 Compositions for treatment and/or prevention of autoimmune disorders
09/18/2014WO2014146069A1 Inhibition of central nervous system effects from smoking and sensory effects from smoking
09/18/2014WO2014146059A1 Halogenopyrazoles as inhibitors of thrombin
09/18/2014WO2014146053A2 Systems and methods for evaluating hyperspectral imaging data using a two layer media model of human tissue
09/18/2014WO2014146044A1 Administration of nicotinamide mononucleotide in the treatment of disease
09/18/2014WO2014145986A1 Multisubstituted aromatic compounds as serine protease inhibitors
09/18/2014WO2014145973A1 Production of low emission biomass fuel
09/18/2014WO2014145946A2 Methods and devices for affecting nerve function
09/18/2014WO2014145874A1 Therapeutic methods
09/18/2014WO2014145857A1 TARGETING THE mTOR PATHWAY IN NEUROLOGICAL DISEASE
09/18/2014WO2014145839A2 Liposomal vaccine adjuvants and methods of processing or using same
09/18/2014WO2014145807A1 Process for the preparation of 4-amino-1-((1s,4r, 5s)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1h-pyrimidin-2-one
09/18/2014WO2014145781A1 Lipobalanced long chain testosterone esters for oral delivery
09/18/2014WO2014145751A2 Targeted therapies for cancer
09/18/2014WO2014145715A1 Metabolites of n-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide
09/18/2014WO2014145710A1 Parenteral diclofenac composition
09/18/2014WO2014145701A2 Automatically deployable communications system
09/18/2014WO2014145700A2 An apparatus and method for producing a thatch roofing material for building construction
09/18/2014WO2014145693A1 Metabolites of n-[3-fluoro-4-({ 6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
09/18/2014WO2014145625A1 Compositions and methods for promoting the generation of endocrine cells
09/18/2014WO2014145617A2 Novel uses
09/18/2014WO2014145600A1 Ach-0142684 sodium salt polymorphs, composition including the same, and method of manufacture thereof
09/18/2014WO2014145580A1 Neosaxitoxin combination formulations for prolonged local anesthesia
09/18/2014WO2014145512A2 Potent small molecule inhibitors of autophagy, and methods of use thereof
09/18/2014WO2014145485A2 Map kinase modulators and uses thereof
09/18/2014WO2014145464A1 Nucleoside analog salts with improved solubility and methods of forming same
09/18/2014WO2014145403A1 Substituted indol-5-ol derivatives and their therapeutic applications
09/18/2014WO2014145389A1 Inhibition of pulmonary fibrosis with nutlin-3a and peptides
09/18/2014WO2014145331A1 Methods, compounds, and compositions for the treatment of angiotensin-related diseases
09/18/2014WO2014145316A1 Methods for identifying neuroprotective pkc activators
09/18/2014WO2014145310A2 Systems and methods for gamified audience interaction platform
09/18/2014WO2014145308A1 Compositions and methods for delivering therapeutic and imaging agents to the sinuses and middle ear
09/18/2014WO2014145303A1 Intravenous emulsions of triptolide as immunomodulators and anticancer agents i
09/18/2014WO2014145295A1 Topical compositions for reducing aging effects
09/18/2014WO2014145220A2 Vehicular high power electrical system and system and method for using voltage bus levels to signal system conditions
09/18/2014WO2014145214A2 Inhibitors of prmt5 and methods of their use
09/18/2014WO2014145210A1 Convergent processes for preparing macrolide antibacterial agents
09/18/2014WO2014145207A1 Substituted gemcitabine bicyclic amide analogs and treatment methods using same
09/18/2014WO2014145205A2 Methods and compositions of p27kip1 transcription modulators
09/18/2014WO2014145192A1 Organic compounds
09/18/2014WO2014145187A1 Controlled drug release liposome composition
09/18/2014WO2014145126A2 Methods of treating dyskinesia and related disorders
09/18/2014WO2014145118A1 Resorufin derivatives for treatment of oxidative stress disorders
09/18/2014WO2014145109A1 Sugar-linker-drug conjugates
09/18/2014WO2014145095A1 Macrocyclic and bicyclic inhibitors of hepatitis c virus
09/18/2014WO2014145093A1 Fine dry particulate resveratrol active agent compositions and topical formulations including the same
09/18/2014WO2014145072A1 Gummy compositions for nutritional supplementation
09/18/2014WO2014145068A1 Compositions, formulations and methods for treating ocular diseases
09/18/2014WO2014145067A1 Topical compositions of flunisolide and methods of treatment
09/18/2014WO2014145051A1 Heterocyclic compounds and uses thereof
09/18/2014WO2014145040A1 Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
09/18/2014WO2014145037A1 Methods and compositions for enhancing oxygen levels in tissues
09/18/2014WO2014145025A2 2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities
09/18/2014WO2014145022A1 Hybrid necroptosis inhibitors
09/18/2014WO2014145004A1 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
09/18/2014WO2014144953A1 Ganglioside compositions
09/18/2014WO2014144952A2 Modulators of the eif2alpha pathway
09/18/2014WO2014144944A1 Desethylhydroxychloroquine for the treatment of diseases associated with inflammation
09/18/2014WO2014144894A1 Methods and systems for conditioning of particulate crystalline materials
09/18/2014WO2014144891A2 Broad spectrum natural preservative composition
09/18/2014WO2014144871A1 Cytotoxic and anti-mitotic compounds, and methods of using the same
09/18/2014WO2014144858A1 Therapeutic methods for treating solid tumors and related diagnostic methods
09/18/2014WO2014144850A1 Methods of treating cancer and preventing cancer drug resistance
09/18/2014WO2014144801A1 Methods and compositions for improving cognitive function
09/18/2014WO2014144786A1 Novel vaccines against multiple subtypes of dengue virus
09/18/2014WO2014144781A1 Combination therapy
09/18/2014WO2014144772A1 Methods of promoting wound healing using crm1 inhibitors
09/18/2014WO2014144765A1 Seaweed extracts, unsaturated aldehydes, and methods of treatment
09/18/2014WO2014144747A1 Substituted 6,5-fused bicyclic heteroaryl compounds
09/18/2014WO2014144737A1 Heteroaryl compounds and uses thereof
09/18/2014WO2014144663A1 Methods and compositions for improving cognitive function
09/18/2014WO2014144659A1 Pyrazole derivatives as prmt1 inhibitors and uses thereof
09/18/2014WO2014144654A1 Compounds for stabilizing ryanodine receptors from aberrant levels of calcium release
09/18/2014WO2014144651A2 An intelligent and configurable fluid delivery system and methods for its use
09/18/2014WO2014144610A1 Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions
09/18/2014WO2014144592A2 Using truncated guide rnas (tru-grnas) to increase specificity for rna-guided genome editing
09/18/2014WO2014144547A2 Amide derivatives of lactam based n-acylethanolamine acid amidase (naaa) inhibitors
09/18/2014WO2014144546A1 Methods and compositons for improving cognitive function
09/18/2014WO2014144545A2 Substituted benzoxazoles and methods of use thereof
09/18/2014WO2014144487A1 System and method of sending pci express data over ethernet connection
09/18/2014WO2014144485A1 Bile acid recycling inhibitors for treatment of barrett's esophagus and gastroesophageal reflux disease
09/18/2014WO2014144455A1 1 -phenoxy-3-(alkylamino)-propan-2-ol derivatives as carm1 inhibitors and uses thereof
09/18/2014WO2014144451A2 Biomarkers for response to rapamycin analogs
09/18/2014WO2014144405A1 Use of mtor inhibitors for prevention of neuroendocrine tumor development and growth
09/18/2014WO2014144366A1 Steroid hormone delivery systems and methods of preparing the same
09/18/2014WO2014144346A1 Use of inhibitors of mtor to improve vascular functions in apoe4 carriers
09/18/2014WO2014144342A1 Non-peptide bdnf neurotrophin mimetics
09/18/2014WO2014144326A1 Transient protection of normal cells during chemotherapy
09/18/2014WO2014144295A1 Ceftolozane antibiotic compositions
09/18/2014WO2014144285A1 Meropenem derivatives and uses thereof
09/18/2014WO2014144272A1 Synergistic combinations of monochlorourea and modified monochloroureas
09/18/2014WO2014144241A1 Sublingual and buccal film compositions
09/18/2014WO2014144227A1 Magnesium compositions and uses thereof for cancers
09/18/2014WO2014144097A1 Antifungal drugs
1 ... 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 ... 7860